Breaking News Instant updates and real-time market news.

ABT

Abbott

$63.60

1.73 (2.80%)

14:43
03/11/18
03/11
14:43
03/11/18
14:43

Abbott announces new long-term data for HeartMate 3 heart pump

Abbott announced new clinical trial data from the Momentum 3 clinical study, what is calls the largest left ventricular assist device trial in the world to evaluate patients in need of both short-term and long-term support in a single study. The data were published online in The New England Journal of Medicine and presented during a late-breaking session at the American College of Cardiology's Scientific Session. "The long-term data for the pivotal MOMENTUM 3 trial demonstrate overall survival of 83 percent at 2-years and marked improvement in clinical outcomes for our patients suffering with advanced heart failure," said Mandeep R. Mehra, M.D., medical director of Brigham and Women's Hospital Heart and Vascular Center in Boston. "We have seen greater pump durability-mostly driven by an absence of confirmed pump thrombosis-as well as a significantly lowered stroke rate without an increase in other adverse events." The Momentum 3 study data-which will be submitted to the FDA to support consideration of a long-term indication for Abbott's HeartMate 3 LVAD-compared the HeartMate 3 LVAD to the HeartMate II LVAD in treating advanced heart failure, the company said. The long-term cohort met its primary endpoint with 77.9% event free survival, showing superiority over the HeartMate II LVAD at 56.4%. Patients with the HeartMate 3 LVAD had a survival rate of 82.8% at two years compared to 76.2% for those with the HeartMate II LVAD. Rates remained at 1.2% suspected thrombosis for the HeartMate 3 LVAD, with no reoperations, pump replacements or urgent transplants occurring at two years. Stroke rate lower by 10% for the HeartMate 3 LVAD compared to the HeartMate II LVAD at 19, Abbott added.

  • 13

    Mar

  • 05

    Apr

ABT Abbott
$63.60

1.73 (2.80%)

01/30/18
ARGS
01/30/18
NO CHANGE
Target $80
ARGS
Buy
Abbott price target raised to $80 from $66 at Argus
Argus analyst David Toung raised his price target on Abbott to $80 and kept his Buy rating after strong Q4 top-line growth. Toung says the company's future expansion will be driven by the acquisitions of St. Jude Medical and Alere, as well as by the recent launch of new products, which merit a premium valuation.
02/12/18
OPCO
02/12/18
NO CHANGE
Target $67
OPCO
Outperform
Dexcom price target lowered to $67 from $72 at Oppenheimer
Oppenheimer analyst Steven Lichtman lowered his price target for Dexcom (DXCM) to $67 from $72 on lowered estimates, while reiterating an Outperform rating on the stock. The analyst recently surveyed high-volume U.S. endocrinologists on the latest in continuous glucose monitoring now with Abbott's (ABT) Libre Flash on the market. According to respondents, there is some impact on Dexcom new prescriptions since Libre launch and some current Dexcom patients are interested in switching, but the impact looks within expectations, he contends. Overall, Lichtman believes the rollouts of Libre and Medtronic's (MDT) 670G remain overhangs on Dexcom near-term, but his survey suggests an environment no worse than guidance and conditions on the ground should change again in 2H18 with approval of Dexcom's next-generation G6.
02/27/18
JPMS
02/27/18
NO CHANGE
JPMS
Abbott's strong Libre launch supports cautious Dexcom stance, says JPMorgan
Abbott's Libre launch is off to a strong start in the U.S. with more than 25,000 patients having started on the device since the launch in early December, JPMorgan analyst Michael Weinstein tells investors in a research note. It remains way too early, however, to say what percent of patients will stick with the device, the analyst adds. The Libre launch reinforces the analyst's cautious stance on shares of Dexcom (DXCM). He expects Dexcom's growth to slow over the course of the year and for 2019 to prove "much more challenging" than 2018. Weinstein has an Overweight rating on Abbott and Neutral rating on Dexcom.
02/28/18
LSCM
02/28/18
NO CHANGE
Target $38
LSCM
Buy
Surmodics price target raised to $38 from $35 at Lake Street
Lake Street analyst Brooks O'Neil raised his price target for Surmodics (SRDX) to $38 saying the company's strategic agreement with Abbott Laboratories (ABT) is a "game changer." The deal validates Surmodics' "whole products" strategy, and provides both a financial and strategic runway for SurVeil, O'Neil tells investors in a research note. He keeps a Buy rating on the shares.

TODAY'S FREE FLY STORIES

AGIO

Agios Pharmaceuticals

$91.06

-0.23 (-0.25%)

, CELG

Celgene

$85.09

-0.26 (-0.30%)

20:07
07/22/18
07/22
20:07
07/22/18
20:07
Recommendations
Agios Pharmaceuticals, Celgene analyst commentary at Piper Jaffray »

Agios' Tibsovo…

AGIO

Agios Pharmaceuticals

$91.06

-0.23 (-0.25%)

CELG

Celgene

$85.09

-0.26 (-0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 21

    Aug

SYNT

Syntel

$39.15

0.14 (0.36%)

, FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

19:25
07/22/18
07/22
19:25
07/22/18
19:25
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

SYNT

Syntel

$39.15

0.14 (0.36%)

FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

PM

Philip Morris

$84.31

3.41 (4.22%)

RACE

Ferrari

$139.98

-2.65 (-1.86%)

AMZN

Amazon.com

$1,813.84

0.99 (0.05%)

NFLX

Netflix

$361.33

-2.81 (-0.77%)

TSLA

Tesla

$313.49

-6.85 (-2.14%)

SNE

Sony

$52.97

0.355 (0.67%)

AB

AllianceBernstein

$29.90

-0.05 (-0.17%)

BLK

BlackRock

$503.01

-1.42 (-0.28%)

BEN

Franklin Resources

$31.99

-0.28 (-0.87%)

IVZ

Invesco

$25.46

-0.245 (-0.95%)

LM

Legg Mason

$33.37

-0.13 (-0.39%)

TROW

T. Rowe Price

$119.87

-0.85 (-0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 26

    Jul

  • 27

    Jul

  • 01

    Aug

  • 01

    Aug

  • 06

    Aug

  • 07

    Aug

  • 15

    Aug

  • 16

    Aug

  • 16

    Aug

INDB

Independent Bank

$88.10

6.45 (7.90%)

17:48
07/22/18
07/22
17:48
07/22/18
17:48
Upgrade
Independent Bank rating change at Keefe Bruyette »

Independent Bank upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHLB

Berkshire Hills Bancorp

$41.40

0.45 (1.10%)

17:47
07/22/18
07/22
17:47
07/22/18
17:47
Downgrade
Berkshire Hills Bancorp rating change at Keefe Bruyette »

Berkshire Hills…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Acquired by T

$0.00

(0.00%)

, CMCSA

Comcast

$34.30

-0.61 (-1.75%)

17:14
07/22/18
07/22
17:14
07/22/18
17:14
Hot Stocks
Box Office Battle: 'Equalizer 2' beats 'Mamma Mia: Here We Go Again!' »

Sony's (SNE)…

TWX

Acquired by T

$0.00

(0.00%)

CMCSA

Comcast

$34.30

-0.61 (-1.75%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$52.97

0.355 (0.67%)

FOX

21st Century Fox

$45.69

-0.5 (-1.08%)

FOXA

21st Century Fox

$46.01

-0.54 (-1.16%)

LGF.A

Lionsgate

$24.88

-0.08 (-0.32%)

DIS

Disney

$111.48

-0.66 (-0.59%)

VIAB

Viacom

$27.49

-0.51 (-1.82%)

VIA

Viacom

$32.10

-0.3 (-0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 26

    Jul

  • 27

    Jul

  • 27

    Jul

  • 07

    Aug

  • 09

    Aug

  • 09

    Aug

  • 09

    Aug

BGNE

BeiGene

$169.98

5.95 (3.63%)

16:43
07/22/18
07/22
16:43
07/22/18
16:43
Hot Stocks
BeiGene planning to pursue accelerated approval in U.S. of Zanubrutinib in WM »

BeiGene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$169.98

5.95 (3.63%)

16:40
07/22/18
07/22
16:40
07/22/18
16:40
Hot Stocks
BeiGene announces preliminary topline results of Hodgkin's Lymphoma trial »

BeiGene announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYNT

Syntel

$39.15

0.14 (0.36%)

16:17
07/22/18
07/22
16:17
07/22/18
16:17
Earnings
Syntel reports preliminary Q2 EPS 49c, consensus 44c »

Reports preliminary Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 06

    Aug

  • 15

    Aug

  • 16

    Aug

SYNT

Syntel

$39.15

0.14 (0.36%)

16:13
07/22/18
07/22
16:13
07/22/18
16:13
Hot Stocks
Syntel enters definitive agreement to be acquired by Atos S.E. »

Syntel announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 06

    Aug

  • 15

    Aug

  • 16

    Aug

DDE

Dover Downs

$2.04

0.01 (0.49%)

16:11
07/22/18
07/22
16:11
07/22/18
16:11
Hot Stocks
Dover Downs to combine with Twin River Worldwide »

Dover Downs and Twin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWO

Two Harbors

$15.92

-0.05 (-0.31%)

, CYS

CYS Investments

$7.57

-0.025 (-0.33%)

13:36
07/22/18
07/22
13:36
07/22/18
13:36
Conference/Events
CYS Investments to host special shareholder meeting »

Special Shareholder…

TWO

Two Harbors

$15.92

-0.05 (-0.31%)

CYS

CYS Investments

$7.57

-0.025 (-0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

  • 08

    Aug

CYS

CYS Investments

$7.57

-0.025 (-0.33%)

, TWO

Two Harbors

$15.92

-0.05 (-0.31%)

13:34
07/22/18
07/22
13:34
07/22/18
13:34
Conference/Events
Two Harbors to host special shareholder meeting »

Special Shareholder…

CYS

CYS Investments

$7.57

-0.025 (-0.33%)

TWO

Two Harbors

$15.92

-0.05 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

JD

JD.com

$35.50

-1.37 (-3.72%)

13:28
07/22/18
07/22
13:28
07/22/18
13:28
Periodicals
JD.com plans move into Europe, Reuters reports »

JD.com's chief…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$191.29

-0.66 (-0.34%)

12:37
07/22/18
07/22
12:37
07/22/18
12:37
Periodicals
China aiming to supply Apple with OLED smartphone screens, WSJ says »

China's campaign to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

PZZA

Papa John's

$51.61

0.62 (1.22%)

12:30
07/22/18
07/22
12:30
07/22/18
12:30
Periodicals
Papa John's board to discuss 'poison pill,' WSJ reports »

Papa John's board…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EADSY

Airbus

$0.00

(0.00%)

, BAESY

BAE Systems

$0.00

(0.00%)

12:22
07/22/18
07/22
12:22
07/22/18
12:22
Periodicals
Airbus CEO says open to jet fighter merger with BAE Systems, Reuters reports »

The chief executive of…

EADSY

Airbus

$0.00

(0.00%)

BAESY

BAE Systems

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$0.00

(0.00%)

12:17
07/22/18
07/22
12:17
07/22/18
12:17
Periodicals
Volkswagen parking cars due to new emissions testing bottlenecks, Reuters says »

Volkswagen is renting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KKR

KKR

$27.26

0.21 (0.78%)

12:11
07/22/18
07/22
12:11
07/22/18
12:11
Hot Stocks
KKR consortium proposes acquisition of LCY Chemical »

LCY Chemical and global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

PM

Philip Morris

$84.31

3.41 (4.22%)

, RACE

Ferrari

$139.98

-2.65 (-1.86%)

11:58
07/22/18
07/22
11:58
07/22/18
11:58
Hot Stocks
Philip Morris' non-executive board chairman to assume CEO role at Ferrari »

Philip Morris (PM) said…

PM

Philip Morris

$84.31

3.41 (4.22%)

RACE

Ferrari

$139.98

-2.65 (-1.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

MDLZ

Mondelez

$42.46

0.21 (0.50%)

11:55
07/22/18
07/22
11:55
07/22/18
11:55
Hot Stocks
Mondelez conducts voluntary recall of certain Ritz Cracker sandwiches »

Mondelez Global announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

ACN

Accenture

$166.47

-0.47 (-0.28%)

, EADSY

Airbus

$0.00

(0.00%)

04:55
07/22/18
07/22
04:55
07/22/18
04:55
Conference/Events
Farnborough International to hold an airshow »

Farnborough International…

ACN

Accenture

$166.47

-0.47 (-0.28%)

EADSY

Airbus

$0.00

(0.00%)

ATI

Allegheny Technologies

$26.65

0.08 (0.30%)

BAESY

BAE Systems

$0.00

(0.00%)

BDRBF

Bombardier

$0.00

(0.00%)

CAE

CAE

$20.96

0.17 (0.82%)

CW

Curtiss-Wright

$125.79

-0.12 (-0.10%)

DASTY

Dassault Systemes

$0.00

(0.00%)

ESLT

Elbit Systems

$118.98

0.64 (0.54%)

LMT

Lockheed Martin

$322.76

3.09 (0.97%)

BA

Boeing

$354.92

-0.57 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 24

    Jul

  • 25

    Jul

  • 26

    Jul

  • 30

    Jul

  • 02

    Aug

  • 06

    Aug

  • 16

    Aug

FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

13:14
07/21/18
07/21
13:14
07/21/18
13:14
Hot Stocks
Fiat names Jeep head as CEO as Marchionne's health worsens »

In a statement, Fiat…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RACE

Ferrari

$139.98

-2.65 (-1.86%)

, PM

Philip Morris

$84.31

3.41 (4.22%)

13:10
07/21/18
07/21
13:10
07/21/18
13:10
Hot Stocks
Ferrari to name former Philip Morris chairman as CEO »

The Board of Directors of…

RACE

Ferrari

$139.98

-2.65 (-1.86%)

PM

Philip Morris

$84.31

3.41 (4.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

AMZN

Amazon.com

$1,813.84

0.99 (0.05%)

, TM

Toyota

$131.87

0.11 (0.08%)

12:51
07/21/18
07/21
12:51
07/21/18
12:51
Periodicals
Amazon, others working to counter Trump's tariff plans, Reuters says »

Big companies in the…

AMZN

Amazon.com

$1,813.84

0.99 (0.05%)

TM

Toyota

$131.87

0.11 (0.08%)

AA

Alcoa

$40.32

-1.36 (-3.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 16

    Aug

FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

12:47
07/21/18
07/21
12:47
07/21/18
12:47
Periodicals
Fiat Chrysler's Sergio Marchionne to step down, NYTimes reports »

Fiat Chrysler's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.